1
|
Zahar S, De Longis E, Hudry J. Revealing the Acute Effects of Dietary Components on Mood and Cognition: The Role of Autonomic Nervous System Responses. Brain Sci 2023; 13:1177. [PMID: 37626533 PMCID: PMC10452653 DOI: 10.3390/brainsci13081177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/01/2023] [Accepted: 08/01/2023] [Indexed: 08/27/2023] Open
Abstract
A growing body of literature suggests dietary components can support mood and cognitive function through the impact of their bioactive or sensorial properties on neural pathways. Of interest, objective measures of the autonomic nervous system-such as those regulating bodily functions related to heartbeat and sweating-can be used to assess the acute effects of dietary components on mood and cognitive function. Technological advancements in the development of portable and wearable devices have made it possible to collect autonomic responses in real-world settings, creating an opportunity to study how the intake of dietary components impacts mood and cognitive function at an individual level, day-to-day. In this paper, we aimed to review the use of autonomic nervous system responses such as heart rate or skin galvanic response to investigate the acute effects of dietary components on mood and cognitive performance in healthy adult populations. In addition to examining the existing methodologies, we also propose new state-of-the-art techniques that use autonomic nervous system responses to detect changes in proxy patterns for the automatic detection of stress, alertness, and cognitive performance. These methodologies have potential applications for home-based nutrition interventions and personalized nutrition, enabling individuals to recognize the specific dietary components that impact their mental and cognitive health and tailor their nutrition accordingly.
Collapse
Affiliation(s)
- Sélima Zahar
- Brain Health Department, Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland; (E.D.L.); (J.H.)
- Center for Neuroprosthetics, Neuro-X Institute, École Polytechnique Fédérale De Lausanne (EPFL), 1202 Geneva, Switzerland
| | - Evelina De Longis
- Brain Health Department, Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland; (E.D.L.); (J.H.)
| | - Julie Hudry
- Brain Health Department, Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland; (E.D.L.); (J.H.)
| |
Collapse
|
2
|
Quiquempoix M, Drogou C, Erblang M, Van Beers P, Guillard M, Tardo-Dino PE, Rabat A, Léger D, Chennaoui M, Gomez-Merino D, Sauvet F. Relationship between Habitual Caffeine Consumption, Attentional Performance, and Individual Alpha Frequency during Total Sleep Deprivation. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:4971. [PMID: 36981883 PMCID: PMC10049386 DOI: 10.3390/ijerph20064971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 03/07/2023] [Accepted: 03/09/2023] [Indexed: 06/18/2023]
Abstract
(1) Background: Caffeine is a psychostimulant that is well known to mitigate the deleterious effects of sleep debt. Our aim was to assess the effects of acute caffeine intake on cognitive vulnerability and brain activity during total sleep deprivation (TSD), taking into account habitual caffeine consumption. (2) Methods: Thirty-seven subjects were evaluated in a double-blind, crossover, total sleep deprivation protocol with caffeine or placebo treatment. Vigilant attention was evaluated every six hours during TSD using the psychomotor vigilance test (PVT) with EEG recordings. The influence of habitual caffeine consumption was analyzed by categorizing subjects into low, moderate, and high consumers. (3) Results: The PVT reaction time (RT) increased during TSD and was lower in the caffeine condition vs. the placebo condition. The RT was shorter in the low-caffeine consumers compared to moderate and high consumers, regardless of conditions and treatments. The TSD-related increase in EEG power was attenuated by acute caffeine intake independently of habitual caffeine consumption, and the individual alpha frequency (IAF) was lower in the high-consumption group. The IAF was negatively correlated with daytime sleepiness. Moreover, a correlation analysis showed that the higher the daily caffeine consumption, the higher the RT and the lower the IAF. (4) Conclusions: A high level of habitual caffeine consumption decreases attentional performance and alpha frequencies, decreasing tolerance to sleep deprivation.
Collapse
Affiliation(s)
- Michael Quiquempoix
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| | - Catherine Drogou
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| | - Mégane Erblang
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
- Laboratoire de Biologie de l’Exercice pour la Performance et la Santé (UMR LBEPS), Université d’Evry, 91025 Evry-Courcouronnes, France
| | - Pascal Van Beers
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| | - Mathias Guillard
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| | - Pierre-Emmanuel Tardo-Dino
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
- Laboratoire de Biologie de l’Exercice pour la Performance et la Santé (UMR LBEPS), Université d’Evry, 91025 Evry-Courcouronnes, France
| | - Arnaud Rabat
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| | - Damien Léger
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
- APHP, Hôtel-Dieu, Centre du Sommeil et de la Vigilance, 75004 Paris, France
| | - Mounir Chennaoui
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| | - Danielle Gomez-Merino
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| | - Fabien Sauvet
- Institut de Recherche Biomédicale des Armées (IRBA), 91223 Brétigny sur Orge, France (F.S.)
- URP 7330 VIFASOM, Université Paris Cité, Hôtel-Dieu, 75004 Paris, France
| |
Collapse
|
3
|
Irwin C, McCartney D, Grant G, Delang N, Bartrim K, Cox GR, Desbrow B. Effects of Different Sources of Low-Dose Caffeine on Mood/Arousal and Cognitive Performance. Percept Mot Skills 2022; 129:1672-1690. [PMID: 36040101 DOI: 10.1177/00315125221124369] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In this study we investigated the effects of variously derived sources of low-dose caffeine on mood/arousal and cognitive performance. Twenty-two participants (15 men, 7 women; M age: 28.2, SD = 9.0 years) undertook five randomized, crossover trials in which they consumed either a water control (CON) or 80 mg of caffeine from one of four sources (coffee [COF], energy drink [END], capsule [CAP], and dissolvable mouth strip [STR]). We measured the participants' perceived efficacy of these varied caffeine sources pre-treatment; and we measured mood/arousal at pre-treatment, and again at 15 and 45 minutes post-treatment. We also measured choice reaction-time at 15 and 45 minutes post-treatment, and participants completed the psychomotor vigilance task (PVT) 45 minutes post-treatment. Caffeine increased participant ratings of alertness and decreased their ratings of tiredness irrespective of source (p's < .05), and all sources of caffeine decreased reaction time on the PVT (p's < .05), with ex-Gaussian distributional analysis localizing this to the tau-parameter, indicating lower variability. However, only the COF source was associated with improved 'overall mood' (p's < .05). Participants expected to perform better on the PVT with COF compared to CON, but there were no other significant associations between source expectancy and performance. In sum, a modest dose of caffeine, regardless of source, positively impacted mood/arousal and cognitive performance, and these effects did not appear to be influenced by expectations.
Collapse
Affiliation(s)
- Christopher Irwin
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia.,Menzies Health Institute Queensland, Australia
| | - Danielle McCartney
- School of Psychology, Faculty of Science, 4334University of Sydney, Sydney, NSW, Australia
| | - Gary Grant
- School of Pharmacy and Medical Sciences, 97562Griffith University, Gold Coast, QLD, Australia
| | - Nathan Delang
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia
| | - Karly Bartrim
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia
| | - Gregory R Cox
- Faculty of Health Sciences and Medicine, 3555Bond University, Robina, QLD, Australia
| | - Ben Desbrow
- School of Health Sciences and Social Work, 97562Griffith University, Gold Coast, QLD, Australia.,Menzies Health Institute Queensland, Australia
| |
Collapse
|
4
|
Zhang RC, Madan CR. How does caffeine influence memory? Drug, experimental, and demographic factors. Neurosci Biobehav Rev 2021; 131:525-538. [PMID: 34563564 DOI: 10.1016/j.neubiorev.2021.09.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Revised: 09/10/2021] [Accepted: 09/17/2021] [Indexed: 11/29/2022]
Abstract
Caffeine is a widely used nootropic drug, but its effects on memory in healthy participants have not been sufficiently evaluated. Here we review evidence of the effects of caffeine on different types of memory, and the associated drug, experimental, and demographical factors. There is limited evidence that caffeine affects performance in memory tasks beyond improved reaction times. For drug factors, a dose-response relationship may exist but findings are inconsistent. Moreover, there is evidence that the source of caffeine can modulate its effects on memory. For experimental factors, past studies often lacked a baseline control for diet and sleep and none discussed the possible reversal of withdrawal effect due to pre-experimental fasting. For demographic factors, caffeine may interact with sex and age, and the direction of the effect may depend on the dose, individual tolerance, and metabolism at baseline. Future studies should incorporate these considerations, as well as providing continued evidence on the effect of caffeine in visuospatial, prospective, and implicit memory measures.
Collapse
Affiliation(s)
- Ruo-Chong Zhang
- School of Psychology, University of Nottingham, Nottingham, UK.
| | | |
Collapse
|
5
|
Erblang M, Sauvet F, Drogou C, Quiquempoix M, Van Beers P, Guillard M, Rabat A, Trignol A, Bourrilhon C, Erkel MC, Léger D, Thomas C, Gomez-Merino D, Chennaoui M. Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882). Genes (Basel) 2021; 12:555. [PMID: 33920292 PMCID: PMC8069049 DOI: 10.3390/genes12040555] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 04/06/2021] [Accepted: 04/08/2021] [Indexed: 02/06/2023] Open
Abstract
This study investigated whether four single nucleotide polymorphisms (SNPs) moderated caffeine effects on vigilance and performance in a double-blind and crossover total sleep deprivation (TSD) protocol in 37 subjects. In caffeine (2 × 2.5 mg/kg/24 h) or placebo-controlled condition, subjects performed a psychomotor vigilance test (PVT) and reported sleepiness every six hours (Karolinska sleepiness scale (KSS)) during TSD. EEG was also analyzed during the 09:15 PVT. Carriers of the TNF-α SNP A allele appear to be more sensitive than homozygote G/G genotype to an attenuating effect of caffeine on PVT lapses during sleep deprivation only because they seem more degraded, but they do not perform better as a result. The A allele carriers of COMT were also more degraded and sensitive to caffeine than G/G genotype after 20 h of sleep deprivation, but not after 26 and 32 h. Regarding PVT reaction time, ADORA2A influences the TSD effect but not caffeine, and PER3 modulates only the caffeine effect. Higher EEG theta activity related to sleep deprivation was observed in mutated TNF-α, PER3, and COMT carriers, in the placebo condition particularly. In conclusion, there are genetic influences on neurobehavioral impairments related to TSD that appear to be attenuated by caffeine administration. (NCT03859882).
Collapse
Affiliation(s)
- Mégane Erblang
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
- LBEPS, Univ Evry, IRBA, Université Paris Saclay, 91025 Evry, France;
| | - Fabien Sauvet
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Catherine Drogou
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Michaël Quiquempoix
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Pascal Van Beers
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Mathias Guillard
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Arnaud Rabat
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Aurélie Trignol
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Cyprien Bourrilhon
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- LBEPS, Univ Evry, IRBA, Université Paris Saclay, 91025 Evry, France;
| | - Marie-Claire Erkel
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Damien Léger
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
- APHP, Hôtel-Dieu, Centre du sommeil et de la Vigilance, 75004 Paris, France
| | - Claire Thomas
- LBEPS, Univ Evry, IRBA, Université Paris Saclay, 91025 Evry, France;
| | - Danielle Gomez-Merino
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| | - Mounir Chennaoui
- Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, France; (M.E.); (C.D.); (M.Q.); (P.V.B.); (M.G.); (A.R.); (A.T.); (C.B.); (M.-C.E.); (D.G.-M.); (M.C.)
- EA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, France;
| |
Collapse
|
6
|
Goh WJ, Tan SX, Pastorin G, Ho PCL, Hu J, Lim SH. 3D printing of four-in-one oral polypill with multiple release profiles for personalized delivery of caffeine and vitamin B analogues. Int J Pharm 2021; 598:120360. [PMID: 33548364 DOI: 10.1016/j.ijpharm.2021.120360] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 01/22/2021] [Accepted: 02/01/2021] [Indexed: 02/06/2023]
Abstract
Personalized supplementation has found recent momentum with an estimated global market size of USD 1.6 billion in 2019 and an expected CAGR of 8.5% between 2020 and 2028. Alongside this rising trend, a simple, accurate, inexpensive and flexible method to produce personalized dosage forms of a wide variety of supplements would be beneficial to both the industry players and individual consumers. Here, we present a 3D printing method to fabricate a four-in-one oral polypill with multiple release profiles for personalized delivery of caffeine and vitamin B analogues. The 3D printable formulations were fabricated and optimized from existing FDA GRAS excipients based on their viscosity, shear thinning properties, recovery of paste and mechanical strength. In the polypill, vitamin B analogues and caffeine were used as the model dietary ingredients. We performed a standard 2 stage USP in vitro dissolution test of the polypill, and demonstrated that vitamin B1, B3 and B6 could be immediately released within 30 min, while caffeine could be slowly released over a period of 4 h. This demonstrated the ability dietary supplement containing different ingredients with varying release profiles, all within a single polypill. Throughout the formulation and 3D printing process, there were no detectable changes to the dietary ingredients nor any interactions with the excipients. This method serves as an intriguing complement to traditional manufacturing of oral tablets, especially when flexibility in design, dose, volume and release profiles of each dietary ingredient is required, as exemplified in personalized supplementation.
Collapse
Affiliation(s)
- Wei Jiang Goh
- NUS Graduate School for Integrative Sciences and Engineering, University Hall, Tan Chin Tuan Wing Level 04, #04-02, 21 Lower Kent Ridge Road, Singapore 119077, Singapore; Craft Health Pte Ltd., 21 Bukit Batok Crescent, #10-75, WCEGA Tower, Singapore 658065, Singapore; Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4A, Level 3, 18 Science Drive 4, Singapore 117543, Singapore
| | - Si Xuan Tan
- Craft Health Pte Ltd., 21 Bukit Batok Crescent, #10-75, WCEGA Tower, Singapore 658065, Singapore
| | - Giorgia Pastorin
- Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4A, Level 3, 18 Science Drive 4, Singapore 117543, Singapore
| | - Paul Chi Lui Ho
- Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4A, Level 3, 18 Science Drive 4, Singapore 117543, Singapore
| | - Jun Hu
- Institute of Chemical and Engineering Sciences, Agency for Science, Technology and Research, 1 Pesek Road, Jurong Island, Singapore 627833, Singapore
| | - Seng Han Lim
- Craft Health Pte Ltd., 21 Bukit Batok Crescent, #10-75, WCEGA Tower, Singapore 658065, Singapore; Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4A, Level 3, 18 Science Drive 4, Singapore 117543, Singapore.
| |
Collapse
|
7
|
Balko S, Simonek J, Balko I, Heller J, Chytry V, Balogova K, Gronek P. The influence of different caffeine doses on visual and audial reaction time with different delay from its consumption. Sci Sports 2020. [DOI: 10.1016/j.scispo.2019.11.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
8
|
Sanchis C, Blasco E, Luna FG, Lupiáñez J. Effects of caffeine intake and exercise intensity on executive and arousal vigilance. Sci Rep 2020; 10:8393. [PMID: 32439849 PMCID: PMC7242431 DOI: 10.1038/s41598-020-65197-5] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2019] [Accepted: 04/17/2020] [Indexed: 12/13/2022] Open
Abstract
During physical efforts and sport practice, vigilance is responsible for maintaining an optimal state of activation, guaranteeing the ability to quickly respond and detect unexpected, but critical, stimuli over time. Caffeine and physical exercise are able to modulate the activation state, affecting vigilance performance. The aim of the present work was to assess the specific effects and modulations of caffeine intake and two physical intensities on vigilance components. Participants performed an attentional task (ANTI-Vea) to measure the executive and arousal components of vigilance, in six double-blinded counterbalanced sessions combining caffeine, placebo, or no-ingestion, with light vs. moderate cyclergometer exercise. Exercise at moderate intensity improved executive vigilance with faster overall reaction time (RT), without impairing error rates. Instead, caffeine intake generally improved arousal vigilance. In conclusion, caffeine and acute exercise seems to moderate executive and arousal vigilance in different ways.
Collapse
Affiliation(s)
- Carlos Sanchis
- Faculty of Physical Education & Sport Sciences, Catholic University of Valencia, Valencia, 46001, Spain.
| | - Esther Blasco
- Faculty of Physical Education & Sport Sciences, Catholic University of Valencia, Valencia, 46001, Spain
| | - Fernando G Luna
- Department of Experimental Psychology, Mind, Brain and Behavior Research Center, University of Granada, 18071, Granada, Spain
- Instituto de Investigaciones Psicológicas (IIPsi, CONICET-UNC), Facultad de Psicología, Universidad Nacional de Córdoba, Córdoba, Argentina
| | - Juan Lupiáñez
- Department of Experimental Psychology, Mind, Brain and Behavior Research Center, University of Granada, 18071, Granada, Spain.
| |
Collapse
|
9
|
Melocchi A, Uboldi M, Parietti F, Cerea M, Foppoli A, Palugan L, Gazzaniga A, Maroni A, Zema L. Lego-Inspired Capsular Devices for the Development of Personalized Dietary Supplements: Proof of Concept With Multimodal Release of Caffeine. J Pharm Sci 2020; 109:1990-1999. [PMID: 32112824 DOI: 10.1016/j.xphs.2020.02.013] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Revised: 02/03/2020] [Accepted: 02/18/2020] [Indexed: 12/19/2022]
Abstract
Dietary supplement companies have recently started to focus on the personalization of products and the improvement of the relevant performance. In this respect, a versatile, easy-to-handle capsular delivery platform with customizable content and release kinetics was here proposed and evaluated after filling with caffeine as a model dietary ingredient. In particular, capsular devices comprising 1 to 3 independent inner compartments were attained by Lego-inspired assembly of matching modular units with different wall compositions, manufactured by injection molding and fused deposition modeling 3D printing. Accordingly, one-, two- and three-pulse release profiles of the dietary ingredient were obtained from differently assembled devices following the breakup of the compartments occurring promptly (immediate-release), on pH change (delayed-release) or after tunable lag times (pulsatile-release). The latter release mode would enable the onset of the stimulating effect of caffeine at different times of the day after a single administration when convenient. The performance of each individual compartment only depended on the composition (i.e., promptly soluble, swellable/soluble or enteric soluble polymers) and thickness of its own wall, while it was not affected by the composition and number of joined modular units. Moreover, the delivery platform was extended to include an external gastroresistant shell enclosing previously assembled devices.
Collapse
Affiliation(s)
- Alice Melocchi
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy; Multiply Labs, 1760 Cesar Chavez Street Unit D, 94124 San Francisco, California 94124
| | - Marco Uboldi
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy
| | - Federico Parietti
- Multiply Labs, 1760 Cesar Chavez Street Unit D, 94124 San Francisco, California 94124
| | - Matteo Cerea
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy
| | - Anastasia Foppoli
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy
| | - Luca Palugan
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy
| | - Andrea Gazzaniga
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy
| | - Alessandra Maroni
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy.
| | - Lucia Zema
- Sezione di Tecnologia e Legislazione Farmaceutiche "Maria Edvige Sangalli", Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, via G. Colombo 71, Milan 20133, Italy
| |
Collapse
|
10
|
Al-Shargie F, Tariq U, Mir H, Alawar H, Babiloni F, Al-Nashash H. Vigilance Decrement and Enhancement Techniques: A Review. Brain Sci 2019; 9:brainsci9080178. [PMID: 31357524 PMCID: PMC6721323 DOI: 10.3390/brainsci9080178] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2019] [Revised: 07/18/2019] [Accepted: 07/25/2019] [Indexed: 01/05/2023] Open
Abstract
This paper presents the first comprehensive review on vigilance enhancement using both conventional and unconventional means, and further discusses the resulting contradictory findings. It highlights the key differences observed between the research findings and argues that variations of the experimental protocol could be a significant contributing factor towards such contradictory results. Furthermore, the paper reveals the effectiveness of unconventional means of enhancement in significant reduction of vigilance decrement compared to conventional means. Meanwhile, a discussion on the challenges of enhancement techniques is presented, with several suggested recommendations and alternative strategies to maintain an adequate level of vigilance for the task at hand. Additionally, this review provides evidence in support of the use of unconventional means of enhancement on vigilance studies, regardless of their practical challenges.
Collapse
Affiliation(s)
- Fares Al-Shargie
- Department of Electrical Engineering, Biosciences and Bioengineering Research Institute, American University of Sharjah, Sharjah 26666, United Arab Emirates.
| | - Usman Tariq
- Department of Electrical Engineering, Biosciences and Bioengineering Research Institute, American University of Sharjah, Sharjah 26666, United Arab Emirates
| | - Hasan Mir
- Department of Electrical Engineering, Biosciences and Bioengineering Research Institute, American University of Sharjah, Sharjah 26666, United Arab Emirates
| | - Hamad Alawar
- Dubai Police Headquarters, Dubai 1493, United Arab Emirates
| | - Fabio Babiloni
- Dept. Molecular Medicine, University of Rome Sapienza, 00185 Rome, Italy
- College of Computer Science and Technology, Hangzhou Dianzi University, Hangzhou 310018, China
| | - Hasan Al-Nashash
- Department of Electrical Engineering, Biosciences and Bioengineering Research Institute, American University of Sharjah, Sharjah 26666, United Arab Emirates
| |
Collapse
|
11
|
Konishi Y, Hori H, Ide K, Katsuki A, Atake K, Igata R, Kubo T, Tominaga H, Beppu H, Asahara T, Yoshimura R. Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study. PLoS One 2018; 13:e0202247. [PMID: 30379815 PMCID: PMC6209127 DOI: 10.1371/journal.pone.0202247] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2017] [Accepted: 07/27/2018] [Indexed: 11/19/2022] Open
Abstract
Objective We investigated the effects of a single instance of caffeine intake on neurocognitive functions and driving performance in healthy subjects using an established cognitive battery and a driving simulator system. Methods This study was conducted in a double-blind, randomized, placebo-controlled manner from February 19, 2016 to August 6, 2016. Caffeine intake was discontinued 3 days prior to the study. Participants were randomly assigned to receive 200-mg doses of caffeine or a placebo. Thirty minutes after administration, cognitive functions were evaluated via the Symbol Digit Coding Test (SDC), the Stroop Test (ST), the Shifting Attention Test (SAT) and the Four Part Continuous Performance Test (FPCPT). After the cognitive function tests were conducted, driving performance was evaluated using a driving simulator. We measured the brake reaction time (BRT) in the Harsh-braking test and the standard deviation of the lateral position (SDLP) in the Road-tracking test. Results Of 100 randomized subjects, 50 (50%) of 100 in the caffeine group and 50 (50%) of 100 in the placebo group completed the study. Participants in the caffeine group had more correct responses than participants in the placebo group on the SAT (P = 0.03) and made fewer errors (P = 0.02). Participants in the caffeine group exhibited shorter times in the Harsh-braking test than participants in the placebo group (P = 0.048). Conclusions A single instance of caffeine intake changed some neurocognitive functions and driving performance in healthy volunteers. Trial registration UMIN000023576.
Collapse
Affiliation(s)
- Yuki Konishi
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
- * E-mail:
| | - Hikaru Hori
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Kenta Ide
- Department of Pharmacy, Hospital of the University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Asuka Katsuki
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Kiyokazu Atake
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Ryohei Igata
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Takamitsu Kubo
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Hirotaka Tominaga
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Hiroki Beppu
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Toshio Asahara
- Department of Pharmacy, Hospital of the University of Occupational and Environmental Health, Kitakyushu, Japan
| | - Reiji Yoshimura
- Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan
| |
Collapse
|
12
|
Sun MK. Executive functioning: perspectives on neurotrophic activity and pharmacology. Behav Pharmacol 2018; 29:592-604. [PMID: 30179884 DOI: 10.1097/fbp.0000000000000427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Executive functioning is a high-level cognitive ability, regulating other abilities and behaviors to achieve desired goals. A typical executive task can be defined as the capacity to maintain one's attention on the current task, that is, responding only to the correct but not to distractive stimuli. Impairments of executive functions, or executive dysfunctions, have a growing impact on everyday life and academic achievement and are usually an early feature, and one of the core features, in brain injury and memory and behavioral disorders. Furthermore, emerging evidence indicates that memory therapeutics cannot achieve their clinical benefits in cognition if executive dysfunction is not effectively and simultaneously treated. Improvement of executive functions might be achieved through targeting some signaling pathways in the brain, including the brain-derived neurotrophic factor signaling pathways. These agents may be useful either as stand-alone interventions for patients with executive dysfunction and/or psychiatric and memory disorders or as essential adjuncts to drugs that target the underlying pathology in various brain injury and memory and behavioral disorders.
Collapse
Affiliation(s)
- Miao-Kun Sun
- Blanchette Rockefeller Neurosciences Institute, Morgantown, West Virginia, USA
| |
Collapse
|
13
|
Anderson JR, Hagerdorn PL, Gunstad J, Spitznagel MB. Using coffee to compensate for poor sleep: Impact on vigilance and implications for workplace performance. APPLIED ERGONOMICS 2018; 70:142-147. [PMID: 29866304 DOI: 10.1016/j.apergo.2018.02.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2017] [Revised: 01/02/2018] [Accepted: 02/27/2018] [Indexed: 06/08/2023]
Abstract
Poor sleep negatively impacts vigilance and is associated with reduced well-being and work productivity. While many individuals depend on caffeine to counteract the cognitive consequences of poor sleep and restore optimal work performance, few studies have naturalistically evaluated this strategy. This study examined the effects of coffee on vigilance, comparing individuals based on recent sleep quality. Sixty-nine participants completed two randomized, counterbalanced trials consisting of 237 ml water or coffee (100 mg caffeine), followed by a continuous performance test assessing vigilance at 30, 90, and 120 min. While coffee improved and stabilized reaction time at all three assessments regardless of recent sleep history, its effects on omission and commission errors were seen only at 90 min; coffee increased commission errors and only partially reduced omission errors in individuals reporting poor sleep quality. The use of coffee to combat poor sleep may therefore be detrimental in situations requiring inhibitory control.
Collapse
Affiliation(s)
- Jason R Anderson
- Department of Psychological Sciences, Kent State University, Kent, OH, USA
| | - Payton L Hagerdorn
- Department of Psychological Sciences, Kent State University, Kent, OH, USA
| | - John Gunstad
- Department of Psychological Sciences, Kent State University, Kent, OH, USA
| | | |
Collapse
|
14
|
McLellan TM, Caldwell JA, Lieberman HR. A review of caffeine’s effects on cognitive, physical and occupational performance. Neurosci Biobehav Rev 2016; 71:294-312. [DOI: 10.1016/j.neubiorev.2016.09.001] [Citation(s) in RCA: 253] [Impact Index Per Article: 31.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2016] [Revised: 08/26/2016] [Accepted: 09/04/2016] [Indexed: 12/31/2022]
|